|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/14/23 Organovo Holdings, Inc. 10-K 3/31/23 75:12M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.40M
2: EX-3.4 Articles of Incorporation/Organization or Bylaws HTML 304K
3: EX-4.1 Instrument Defining the Rights of Security Holders HTML 47K
4: EX-10.38 Material Contract HTML 3.05M
5: EX-21.1 Subsidiaries List HTML 22K
6: EX-23.1 Consent of Expert or Counsel HTML 22K
7: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
15: R1 Document and Entity Information HTML 96K
16: R2 Consolidated Balance Sheets HTML 113K
17: R3 Consolidated Balance Sheets (Parenthetical) HTML 32K
18: R4 Consolidated Statements of Operations and Other HTML 95K
Comprehensive Loss
19: R5 Consolidated Statements of Stockholders' Equity HTML 63K
20: R6 Consolidated Statements of Cash Flows HTML 106K
21: R7 Description of Business and Summary of Significant HTML 83K
Accounting Policies
22: R8 Investments and Fair Value Measurement HTML 68K
23: R9 Fixed Assets HTML 55K
24: R10 Accrued Expenses HTML 48K
25: R11 Collaborative Research, Development, and License HTML 77K
Agreements
26: R12 Stockholders' Equity HTML 225K
27: R13 Leases HTML 93K
28: R14 Commitments and Contingencies HTML 29K
29: R15 Income Taxes HTML 157K
30: R16 Concentrations HTML 26K
31: R17 Related Parties HTML 31K
32: R18 Defined Contribution Plan HTML 27K
33: R19 Recent Accounting Pronouncements HTML 35K
34: R20 Description of Business and Summary of Significant HTML 123K
Accounting Policies (Policies)
35: R21 Recent Accounting Pronouncements (Policies) HTML 24K
36: R22 Investments and Fair Value Measurement (Tables) HTML 61K
37: R23 Fixed Assets (Tables) HTML 52K
38: R24 Accrued Expenses (Tables) HTML 47K
39: R25 Collaborative Research, Development, and License HTML 40K
Agreements (Tables)
40: R26 Stockholders' Equity (Tables) HTML 185K
41: R27 Leases (Tables) HTML 77K
42: R28 Income Taxes (Tables) HTML 141K
43: R29 Description of Business and Summary of Significant HTML 74K
Accounting Policies - Additional Information
(Detail)
44: R30 Investments and Fair Value Measurement - HTML 42K
Additional Information (Detail)
45: R31 Investments and Fair Value Measurement - Summary HTML 32K
of Investments in Debt Securities that are
Measured at Fair Value (Detail)
46: R32 Investments and Fair Value Measurement - Schedule HTML 34K
of Activity for Investments in Equity Securities
Measured at Fair Value (Detail)
47: R33 Fixed Assets - Schedule of Fixed Assets (Detail) HTML 36K
48: R34 Fixed Assets - Additional Information (Detail) HTML 24K
49: R35 Accrued Expenses - Summary of Accrued Expenses HTML 33K
(Detail)
50: R36 Collaborative Research, Development, and License HTML 103K
Agreements - Additional Information (Detail)
51: R37 Collaborative Research, Development, and License HTML 30K
Agreements - Schedule of Capitalized License Fees
(Detail)
52: R38 Stockholders' Equity - Preferred Stock - HTML 26K
Additional Information (Detail)
53: R39 Stockholders' Equity - Common Stock - Additional HTML 90K
Information (Detail)
54: R40 Stockholders' Equity - Summary of Company's RSUs HTML 44K
Activity (Detail)
55: R41 Stockholders' Equity - Stock Options and Employee HTML 86K
Stock Purchase Plan - Additional Information
(Detail)
56: R42 Stockholders' Equity - Summary of Stock Option HTML 55K
Activity (Detail)
57: R43 Stockholders' Equity - Common Stock Reserved for HTML 42K
Future Issuance (Detail)
58: R44 Stockholders' Equity - Schedule of Stock-based HTML 29K
Compensation Expense (Detail)
59: R45 Stockholders' Equity - Stock-based Compensation HTML 35K
Expense and Valuation Information - Additional
Information (Detail)
60: R46 Stockholders' Equity - Fair Value of Employee HTML 34K
Stock Options (Detail)
61: R47 Stockholders' Equity - Fair Value of ESPP Shares HTML 38K
(Detail)
62: R48 Stockholders' Equity - Fair Value of Employee HTML 26K
Stock Purchase Plan (Parenthetical) (Detail)
63: R49 Leases - Additional Information (Details) HTML 55K
64: R50 Leases - Schedule of Lease Liabilities and HTML 40K
Corresponding Right-of-use Assets (Details)
65: R51 Leases - Schedule of Future Lease Payments HTML 44K
(Details)
66: R52 Income Taxes - Summary of Reconciliation of HTML 66K
Statutory Federal Rate and Effective Rate for
Operations (Detail)
67: R53 Income Taxes - Summary of Net Deferred Tax Assets HTML 55K
(Detail)
68: R54 Income Taxes - Additional Information (Detail) HTML 53K
69: R55 Related Parties - Additional Information (Detail) HTML 27K
70: R56 Defined Contribution Plan - Additional Information HTML 26K
(Details)
73: XML IDEA XML File -- Filing Summary XML 132K
71: XML XBRL Instance -- onvo-20230331_htm XML 1.72M
72: EXCEL IDEA Workbook of Financial Report Info XLSX 126K
11: EX-101.CAL XBRL Calculations -- onvo-20230331_cal XML 181K
14: EX-101.DEF XBRL Definitions -- onvo-20230331_def XML 516K
10: EX-101.LAB XBRL Labels -- onvo-20230331_lab XML 1.31M
13: EX-101.PRE XBRL Presentations -- onvo-20230331_pre XML 941K
12: EX-101.SCH XBRL Schema -- onvo-20230331 XSD 184K
74: JSON XBRL Instance as JSON Data -- MetaLinks 403± 672K
75: ZIP XBRL Zipped Folder -- 0000950170-23-032889-xbrl Zip 635K
| EX-31.2 |
Exhibit 31.2
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Thomas Hess, Chief Financial Officer of Organovo Holdings, Inc., certify that:
1. I have reviewed this annual report on Form 10-K of Organovo Holdings, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: July 13, 2023 |
|
/s/ Thomas Hess |
|
|
|
|
|
Chief Financial Officer |
|
|
(Principal Financial Officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 7/14/23 | |||
| Filed on: | 7/13/23 | |||
| For Period end: | 3/31/23 | NT 10-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/30/24 Organovo Holdings, Inc. S-1/A 81:12M Donnelley … Solutions/FA 4/12/24 Organovo Holdings, Inc. S-1 76:11M Donnelley … Solutions/FA 2/08/24 Organovo Holdings, Inc. 424B5 1:315K Donnelley … Solutions/FA 2/08/24 Organovo Holdings, Inc. 10-Q 12/31/23 61:6.2M Donnelley … Solutions/FA 1/26/24 Organovo Holdings, Inc. S-3 5:1M Donnelley … Solutions/FA 12/01/23 Organovo Holdings, Inc. S-8 12/01/23 4:98K Donnelley … Solutions/FA 7/31/23 Organovo Holdings, Inc. 10-K/A 3/31/23 12:1.4M Donnelley … Solutions/FA |